Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Cathie Wood's Ark Invests Buys and Sells 2/22
09:20pm, Monday, 22'nd Feb 2021
ARK Invest has been the talk of Wall Street over the last couple of years, outperforming the market and solidifying its place among the big players in the investments world.
Reddit traders follow playbook from 'Queen' Cathie Wood
03:05pm, Monday, 22'nd Feb 2021
CNBC's Kate Rooney reports on the Reddit interest in Ark Invest's Cathie Wood and the growth of Ark Invest's funds.
ARKG: Precautionary Measures, But Transformational Objectives Remain Intact
09:23am, Monday, 22'nd Feb 2021
Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality.
PropTech SPACs: Not Just For The Rich And Famous
07:00am, Monday, 22'nd Feb 2021
PropTech SPACs: Not Just For The Rich And Famous
5 Cathie Wood Stocks That Were Big ARK Invest Buys Last Week
12:44am, Monday, 15'th Feb 2021
Get the latest on the red-hot active ETF manager's moves.
Liquid Biopsies? Just Another Day in the Life for ‘ARKG'
11:36am, Friday, 12'th Feb 2021
When it comes to investing in companies with exposure to the rapidly evolving early cancer detection/screening market, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) stands above the rest.
Best Healthcare ETFs for Q2 2021
04:50pm, Wednesday, 10'th Feb 2021
The best healthcare ETFs for Q2 2021 are ARKG, CNBS, and YOLO.
Cancer Screening? There's an ARK ETF for That
02:10pm, Tuesday, 09'th Feb 2021
Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure. Enter the ARK Genomic Revolution Mult
Ark Invest ETFs Power Active Investing Growth
12:08pm, Tuesday, 09'th Feb 2021
Active ETFs pulled in a record of more than $55 billion capital last year and $17.5 billion so far this year, bringing their AUM to $200 billion.
ARKG: Dynamic And Fluid Enough To Continue To Provide Strong Returns
12:31pm, Monday, 08'th Feb 2021
ARKG has outperformed the high-flying Genomics and Biotech ETF competition over the long and short term. Management has proven that the frequent and large scale changes in the portfolio are a huge ben
6 Hot ETFs That Could be Investors' Darling in February
12:06pm, Thursday, 04'th Feb 2021
A few ETFs have garnered solid investors' interest to start a New Year and will continue to be their darlings in the month of love.
Best Biotech ETFs for Q2 2021
02:25pm, Wednesday, 03'rd Feb 2021
The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.
Unlock the Long-Term Genomics Runway with ‘ARKG'
02:23pm, Wednesday, 03'rd Feb 2021
Ground zero for disruptive growth in the healthcare sector is genomics through the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG holds equity securities of companies across multiple sect
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant
01:02pm, Friday, 29'th Jan 2021
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant
Long Read Sequencing Is Here. The ARKG ETDF Is Ready
11:59am, Friday, 29'th Jan 2021
Next generation sequencing (NGS) is here, and its long-term evolution could spark significant upside for exchange traded funds like the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Long DNA
